Cargando…
Metabolomic and BH3 profiling of esophageal cancers: novel assessment methods for precision therapy
BACKGROUND: Esophageal cancers accounted for nearly 16,000 deaths in 2016. The number of patients with esophageal cancers increases every year. Neoadjuvant chemoradiotherapy (nCRT) prior to esophagectomy is a standard treatment for esophageal cancers. The patients who have no residual tumor (patholo...
Autores principales: | Taylor Ripley, R., Surman, Deborah R., Diggs, Laurence P., Trepel, Jane B., Lee, Min-Jung, Ryan, Jeremy, Davis, Jeremy L., Steinberg, Seth M., Hernandez, Jonathan M., Hoang, Choung, Kenney, Cara M., Bond, Colleen D., Kunst, Tricia F., Letai, Anthony, Schrump, David S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013848/ https://www.ncbi.nlm.nih.gov/pubmed/29933761 http://dx.doi.org/10.1186/s12876-018-0823-x |
Ejemplares similares
-
Therapeutic Synergy in Esophageal Cancer and Mesothelioma Is Predicted by Dynamic BH3 Profiling
por: Surman, Deborah R., et al.
Publicado: (2021) -
Randomized phase II trial of a first-in-human cancer cell lysate vaccine in patients with thoracic malignancies
por: Zhang, Mary, et al.
Publicado: (2021) -
Designed BH3 Peptides with High Affinity and Specificity
for Targeting Mcl-1 in Cells
por: Foight, Glenna Wink, et al.
Publicado: (2014) -
BH3-profiling identifies heterogeneous dependency on Bcl-2 family members in Multiple Myeloma and predicts sensitivity to BH3 mimetics
por: Touzeau, Cyrille, et al.
Publicado: (2015) -
Dynamic BH3 profiling identifies active BH3 mimetic combinations in non-small cell lung cancer
por: Potter, Danielle S., et al.
Publicado: (2021)